Max Healthcare Institute Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

2,135.47

2,027.57

1,909.74

1,868.31

1,707.46

1,542.95

1,422.90

Other Operating Income

0.00

Total Operating income

2,135.47

2,027.57

1,909.74

1,868.31

1,707.46

1,542.95

1,422.90

Raw Material Cost

465.15

453.82

410.14

396.89

359.39

329.99

297.41

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-0.26

-8.58

-0.71

-5.07

-10.15

-3.43

-1.81

Employee Cost

338.32

338.07

315.59

304.60

283.63

270.19

241.84

Power Cost

0.00

Manufacturing Expenses

452.73

426.39

406.34

386.14

354.69

327.53

292.55

Selling and Distribution Expenses

0.00

Other Expenses

304.38

294.96

266.76

286.62

269.36

231.26

211.38

Total Expenditure (Excl Depreciation)

1,560.32

1,504.66

1,398.12

1,369.18

1,256.92

1,155.54

1,041.37

Operating Profit (PBDIT) excl Other Income

575.15

522.91

511.62

499.13

450.54

387.41

381.53

Other Income

32.90

36.51

46.92

33.30

40.84

34.68

45.25

Operating Profit (PBDIT)

608.05

559.42

558.54

532.43

491.38

422.09

426.78

Interest

53.92

54.85

55.21

52.39

33.54

23.88

20.73

Exceptional Items

0.00

-73.63

0.00

Gross Profit (PBDT)

554.13

504.57

503.33

406.41

457.84

398.21

406.05

Depreciation

108.10

104.14

100.83

97.54

84.15

76.90

70.32

Profit Before Tax

446.03

400.43

402.50

308.87

373.69

321.31

335.73

Tax

-45.27

92.46

83.50

70.07

91.88

85.04

84.19

Provisions and contingencies

0.00

Profit After Tax

491.30

307.97

319.00

238.80

281.81

236.27

251.54

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

491.30

307.97

319.00

238.80

281.81

236.27

251.54

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

491.30

307.97

319.00

238.80

281.81

236.27

251.54

Equity Capital

972.24

972.15

972.14

972.13

971.91

Face Value

10.0

Reserves

0.00

Earnings per share (EPS)

5.05

3.17

3.28

2.46

2.9

2.43

2.59

Diluted Earnings per share

5.02

3.15

3.26

2.44

2.88

2.43

2.58

Operating Profit Margin (Excl OI)

26.93%

25.79%

26.79%

26.72%

26.39%

25.11%

26.81%

Gross Profit Margin

25.95%

24.89%

26.36%

21.75%

26.81%

25.81%

28.54%

PAT Margin

23.01%

15.19%

16.7%

12.78%

16.5%

15.31%

17.68%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 5.32% vs 6.17% in Jun 2025

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 59.53% vs -3.46% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 9.99% vs 2.21% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -1.70% vs -0.65% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Max Healthcare With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

2,135.47

6,303.50

-4,168.03

-66.12%

Other Operating Income

0.00

Total Operating income

2,135.47

6,303.50

-4,168.03

-66.12%

Raw Material Cost

465.15

778.70

-313.55

-40.27%

Purchase of Finished goods

0.00

2,464.70

-2,464.70

-100.00%

(Increase) / Decrease In Stocks

-0.26

0.20

-0.46

-230.00%

Employee Cost

338.32

766.70

-428.38

-55.87%

Power Cost

0.00

Manufacturing Expenses

452.73

0.00

452.73

Selling and Distribution Expenses

0.00

Other Expenses

304.38

1,352.10

-1,047.72

-77.49%

Total Expenditure (Excl Depreciation)

1,560.32

5,362.40

-3,802.08

-70.90%

Operating Profit (PBDIT) excl Other Income

575.15

941.10

-365.95

-38.89%

Other Income

32.90

54.70

-21.80

-39.85%

Operating Profit (PBDIT)

608.05

995.80

-387.75

-38.94%

Interest

53.92

109.60

-55.68

-50.80%

Exceptional Items

0.00

Gross Profit (PBDT)

554.13

886.20

-332.07

-37.47%

Depreciation

108.10

217.80

-109.70

-50.37%

Profit Before Tax

446.03

674.70

-228.67

-33.89%

Tax

-45.27

180.70

-225.97

-125.05%

Provisions and contingencies

0.00

Profit After Tax

491.30

487.70

3.60

0.74%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

491.30

487.70

3.60

0.74%

Share in Profit of Associates

0.00

6.30

-6.30

-100.00%

Minority Interest

0.00

16.80

-16.80

-100.00%

Other related items

0.00

Consolidated Net Profit

491.30

477.20

14.10

2.95%

Equity Capital

972.24

71.90

900.34

1,252.21%

Face Value

10.00

5.00

0.00

Reserves

0.00

Earnings per share (EPS)

5.05

33.18

-28.13

-84.78%

Diluted Earnings per share

5.02

33.19

-28.17

-84.87%

Operating Profit Margin (Excl OI)

26.93%

14.93%

0.00

12.00%

Gross Profit Margin

25.95%

14.06%

0.00

11.89%

PAT Margin

23.01%

7.84%

0.00

15.17%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 2,135.47 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 5.32% vs 6.17% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 25.07% vs 25.26% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 491.30 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 59.53% vs -3.46% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 74.34% vs 1.85% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 575.15 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 9.99% vs 2.21% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 27.66% vs 16.31% in Sep 2024

Quarterly - Interest

Interest 53.92 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -1.70% vs -0.65% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 60.76% vs 293.20% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 26.93%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024